Health Canada has given Moderna the green light to launch a clinical trial for a vaccine targeting the Bundibugyo form of the ...

Moderna has started first-in-human testing of its mRNA vaccine against Bundibugyo Ebola virus (BDBV), now causing the ...

Ebola cases double every 20 days in DR Congo as political violence and acute food insecurity hinder containment efforts in the east.

Phase 1 trial will evaluate safety and immune response for a strain of Ebola virus disease with no licensed vaccines ...

A highly contagious Ebola virus species, Bundibugyo virus (BDBV), has driven several outbreaks since 2007, including the ...

As the Bundibugyo Ebola virus outbreak continues to spread in the Democratic Republic of the Congo, the first of four vaccine ...

Moderna launched a human trial of an experimental vaccine to protect against Bundibugyo Ebola strain that has killed more ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The Democratic Republic of Congo has surpassed 1,000 confirmed Ebola cases by June 21, 2026, ...

Recruitment for the vaccination trial has begun, with vaccinations expected to start in the coming weeks • US citizen becomes second to be treated in German hospital • Total DRC cases rise to 1,926 ...

Ebolaviruses are among the most dangerous known human pathogens. Three ebolavirus species have repeatedly caused major ...

Eastern Congo's Ebola outbreak has killed more than 1,700 people as community spread accelerates beyond contact tracing.